Hematology technologies are moving toward more clinical-decision support
Hematology technologies are moving toward more clinical-decision support, where analyzers are capable of providing decision-support reports and tools to physicians/clinicians, enabling creation of correct investigation pathways and care protocols. Flagging for abnormal result is a growing demand where pathologist wants to have customized indicative flagging feature for abnormal cells.
Market demands to reduce the size, cost effectiveness, low maintenance, and reliable date, linearity of the parameter, reproducibility, and accuracy by unique hardware design of the instrument.
Data-management software for hematology instruments is also a key feature of the product. It interprets and carries out the orders of the instrument operator. It gives the clear colored histogram and scatter gram, which is different for every customer and depends on the measurement techniques and parameters measured by the analyzer. The graphical presentation enriches the user experience and helps in reducing operator error.
India has been one of the growing healthcare markets and when it comes to hematology instruments and reagents, it is expected to grow 12 to14 percent per year. The market will grow along with the development of medical system in India. With an increase in awareness about diagnostic tests and a manifold increase in the index of infectious diseases in the country, it has turned out to be a favorable market-growth situation.
Hematology instruments and reagents continue to maintain strong position, and the hematology market globally is expected to reach USD 4.5 billion by 2020.
Over the years, hematology instruments have evolved from simple manual red blood cell counters to sophisticated automated analyzers. Nowadays, it is difficult to find semi-automatic hematology analyzers as they have been already replaced by fully automated analyzers in developed countries. The trend is about to be followed in Tier-III Indian market too.
The analytical automation systems simplify testing process, reduce manual work, and further increase the efficiency and productivity of laboratories. Reliability of the data is one of the key concerns for users. The main factors to secure data reliability are maintenance of instruments, qualified genuine reagents, and daily QC programs using hematology controls. Companies that can provide these factors can dominate with a considerable growth in the market.
